Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
Sophie Davies, Training and Development Supervisor at Bespoke Clinical Services, shared a post on LinkedIn:
“One observation I’ve made during my experience as a clinical pharmacist is that patients often don’t consider supplements to be ‘medications’, so they don’t always mention them during reviews.
During some anticoagulant safety searches, I identified several patients taking omega-3/cod liver oil supplements alongside DOAC therapy.
They were all unaware of the potential additive bleeding risk.
This reinforced how important clear medicine counselling and thorough medication reviews are in reducing preventable harm.
The goal is to translate guidance into practical, usable information to keep patients fully informed.
Small interventions can have a significant impact on patient safety.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 14:30Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress
-
Jul 18, 2026, 14:28Isabelle Salles-Crawley: Science, Collaboration, and Inspiration at ISTH 2026
-
Jul 18, 2026, 14:05Habib Bennaceur: Novo Nordisk Highlights Progress in Rare Bleeding Disorders at ISTH 2026
-
Jul 18, 2026, 13:56C. Heleen van Ommen: IPTN Meeting Highlights Progress in Pediatric Thrombosis
-
Jul 18, 2026, 13:42Chokri Ben Lamine: Optimizing PBSC Donation in Hemoglobinopathy Carriers
-
Jul 18, 2026, 12:17Doruntina Lahu: Prasugrel and Ticagrelor – Does Sex Matter?
-
Jul 18, 2026, 11:54Paul Riley: Presenting STAR Max3 at ISTH 2026
-
Jul 18, 2026, 11:38Abdul Mannan: Normal Blood DEB Test Does Not Always Rule Out Fanconi Anaemia
-
Jul 18, 2026, 10:47Adela Perolla: Lighting the Flame for Future Hematologists